BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

Clinisys Acquires Promium to Further Grow Scientific, Environmental and Public Health Diagnostics Capabilities

Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated...

May 04, 2023 | News

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy i...

May 04, 2023 | News

Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis

Tuberculosis is one of the most contagious diseases that continues to challenge the public health system today. Although the World Health Organizatio...

May 03, 2023 | News

FDA Approves Teva and MedinCell's UZEDY™ for Adult Schizophrenia Treatment

This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a ...

May 01, 2023 | Regulatory

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2023

–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...

May 01, 2023 | News

HOYA elevates children's myopia and light protection with MiYOSMART Sun lenses.

Origins of MiYOSMART lenses Developed by HOYA Vision Care in cooperation with The Hong Kong Polytechnic University, MiYOSMART is a line of innovative opht...

April 30, 2023 | News

Healint announces collaboration with Saitama Medical University Hospital in Japan to verify AI diagnosis of migraine

Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialist...

April 28, 2023 | News

Fosun Pharma Develops Innovative Artemisinin-based Antimalarials for Malaria-free World via Belt and Road

This year 2023 also marks the 10th anniversary of the Belt and Road Initiative. Medicine knows no borders. Artemisinin and its derivatives have moved ...

April 27, 2023 | News

BioSenic Granted Key European Patent for Therapeutic Development in Cancer and Immune Diseases

BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to ma...

April 18, 2023 | News

Zenshine's ZX-7101A Meets Primary Endpoint in Phase 2 Study for Adult Flu Treatment

Interim analysis of the phase 2 cohort of ZX-7101A phase 2/3 adaptive design pivotal study (registration number: CTR20221729), a multicenter, randomized, d...

April 17, 2023 | News

Zenshine's ZX-7101A meets primary endpoint in Phase 2 flu treatment study

Interim analysis of the phase 2 cohort of ZX-7101A phase 2/3 adaptive design pivotal study (registration number: CTR20221729), a multicenter, randomized, d...

April 14, 2023 | News

HealthEquity Partners With Microsoft to Fast-Track the Future of Health Benefits Using Cloud Capabilities

HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”), the nation’s largest health savings account (HSA) custodian, has announced a...

April 05, 2023 | News

PRC Expands Public Health Services to Include Immunization Efforts

PRC, a trusted leader in healthcare experience, is pleased to announce the expansion of its public health services to include working with local health dep...

April 03, 2023 | News

Noul Co. Ltd's The RIGHT Foundation Begins Research and Development to Aid Malaria Control

Noul Co. Ltd (CEO : David Lim) announced that it has signed an agreement with The RIGHT Foundation to conduct a global clinical studies to determine t...

March 28, 2023 | News

Stay Connected